IRIS
CARACCIOLO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 687
EU - Europa 346
AS - Asia 48
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
SA - Sud America 3
Totale 1.094
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 673
IT - Italia 229
GB - Regno Unito 46
SE - Svezia 27
CN - Cina 21
DE - Germania 16
CA - Canada 14
IN - India 13
EU - Europa 7
FR - Francia 5
RU - Federazione Russa 5
ES - Italia 4
HK - Hong Kong 4
JP - Giappone 4
AU - Australia 3
FI - Finlandia 3
NL - Olanda 3
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
IR - Iran 2
SG - Singapore 2
UA - Ucraina 2
BD - Bangladesh 1
CL - Cile 1
GR - Grecia 1
MY - Malesia 1
RO - Romania 1
Totale 1.094
Salva come PNG Salva come JPEG
Città #
Chandler 152
Chicago 47
Lawrence 44
Princeton 44
Catanzaro 42
London 41
Ashburn 38
Wilmington 18
Naples 17
Beijing 13
Des Moines 13
Ottawa 13
Redwood City 8
Santo Stefano di Rogliano 8
Cosenza 7
Rome 7
Melito di Porto Salvo 6
Settingiano 5
Boardman 4
Decollatura 4
Hanover 4
Los Angeles 4
Mountain View 4
Pune 4
Redmond 4
Seattle 4
Acquaviva delle Fonti 3
Ahmedabad 3
Berlin 3
Castrovillari 3
Helsinki 3
Mileto 3
Paola 3
Reggio Calabria 3
San Antonio 3
Treviso 3
Washington 3
Agrigento 2
Andover 2
Bologna 2
Brescia 2
Brighton 2
Campobello di Licata 2
Ceglie Del Campo 2
Delhi 2
Ercolano 2
Esslingen am Neckar 2
Grottaglie 2
Hefei 2
Hong Kong 2
Leawood 2
Madrid 2
New York 2
Palermo 2
Paris 2
Romainville 2
San Jose 2
Serra San Bruno 2
Vigliano Biellese 2
Ann Arbor 1
Apo 1
Arnhem 1
Baotou 1
Bari 1
Belovo 1
Bern 1
Buffalo 1
Byron 1
Canberra 1
Catania 1
Changchun 1
Chemnitz 1
Clearwater 1
Cutro 1
Delta Junction 1
East Lansing 1
Fairfield 1
Fayetteville 1
Frankfurt am Main 1
Hebei 1
Horia 1
Hyderabad 1
Kansas City 1
Kuala Lumpur 1
Melbourne 1
Melito di Napoli 1
Mordano 1
Niterói 1
Pachino 1
Phoenix 1
Roccella Jonica 1
Secaucus 1
Shanghai 1
Singapore 1
Siziano 1
South Woodstock 1
Soverato Marina 1
Squillace 1
St Petersburg 1
São Paulo 1
Totale 673
Salva come PNG Salva come JPEG
Nome #
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 51
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 48
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 48
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 42
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 41
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 39
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 39
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 33
null 31
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 30
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 29
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 29
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 27
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 27
Mmrf-commpass data integration and analysis for identifying prognostic markers 27
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 27
Mir-221/222 are promising targets for innovative anticancer therapy 26
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 25
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 25
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 24
Integration of DNA Microarray with Clinical and Genomic Data 24
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 23
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 22
miR-22 suppresses DNA ligase III addiction in multiple myeloma 22
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 21
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 21
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 20
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 20
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 20
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 20
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 19
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 19
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 19
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 19
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma 18
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 18
Alternative non-homologous end-joining: Error-prone dna repair as cancer’s achilles’ heel 17
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 14
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 13
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 13
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 13
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 12
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 11
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 11
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 11
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 10
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 9
The potential role of miRNAs in multiple myeloma therapy 9
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma. 9
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 9
Synthetic miR-22 impairs NHEJ repair sensistizing multiple myeloma cells to bortezomib-induced BRCAness 7
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches 7
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts 6
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 5
Immunomodulatory activity of microRNAs: potential implications for multiple myeloma treatment. 5
The potential role of miRNAs in multiple myeloma therapy 5
Targeting oncogenic pri-miR-17-92 in multiple myeloma: molecular findings and therapeutic potential 5
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity 4
Totale 1.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 11 7 1 2 0 3 2 8 15
2020/2021132 4 2 9 10 12 9 11 10 25 20 15 5
2021/2022179 4 0 0 27 7 5 11 30 37 31 24 3
2022/2023541 95 29 32 21 64 38 6 39 76 54 68 19
2023/2024297 86 32 36 22 16 83 7 6 1 5 3 0
Totale 1.198